Quark, Fujisawa Ink Drug-Discovery Deal for Stroke | GenomeWeb

NEW YORK, Aug. 6 - Quark Biotech and Japanese pharma firm Fujisawa today said they have penned a drug-discovery collaboration to treat stroke.

Terms of the deal call for Fujisawa to fund the research program, in which Quark will use its high-throughput technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.